Objectives To assess antidepressant response in late-onset major depression in relation to neuropsychological domains: attention, memory and planning. Methods A neuropsychological battery was administered in 30 medication-free patients with late-onset major depression, who were then included in a 12
Late-onset major depression: clinical and treatment-response variability
β Scribed by Henry C. Driscoll; James Basinski; Benoit H. Mulsant; Meryl A. Butters; Mary Amanda Dew; Patricia R. Houck; Sati Mazumdar; Mark D. Miller; Bruce G. Pollock; Jacqueline A. Stack; Mary Ann Schlernitzauer; Charles F. Reynolds III
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- English
- Weight
- 86 KB
- Volume
- 20
- Category
- Article
- ISSN
- 0885-6230
- DOI
- 10.1002/gps.1334
No coin nor oath required. For personal study only.
β¦ Synopsis
Objective To explore clinical and treatment-response variability in late-onset vs early-onset non-bipolar, non-psychotic major depression. Methods We grouped patients from a late-life depression treatment study according to illness-course characteristics: those with early-onset, recurrent depression (n ΒΌ 59), late-onset, recurrent depression (n ΒΌ 27), and late-onset, single-episode depression (n ΒΌ 95). Early-onset was defined as having a first lifetime episode of major depression at age 59 or earlier; late-onset was defined as having a first episode of major depression at age 60 or later. We characterized the three groups of patients with respect to baseline demographic, neuropsychological, and clinical characteristics, use of augmentation pharmacotherapy to achieve response, and treatment outcomes. Results Rates of response, remission, relapse, and termination were similar in all three groups; however, patients with lateonset, recurrent major depression took longer to respond to treatment than those with late-onset, single-episode depression (12 weeks vs 8 weeks) and had more cognitive and functional impairment. Additionally, patients with recurrent depression (whether early or late) were more likely to require pharmacotherapy augmentation to achieve response than patients with a single lifetime episode. Conclusion Late-onset, recurrent depression takes longer to respond to treatment than late-onset single-episode depression and is more strongly associated with cognitive and functional impairment. Further study of biological, neuropsychologic, and psychosocial correlates of late-onset, recurrent depression is needed.
π SIMILAR VOLUMES
## Abstract ## Objective Approximately half of older patients treated for major depressive disorder (MDD) do not achieve symptomatic remission and functional recovery with firstβline pharmacotherapy. This study aims to characterize sociodemographic, clinical, and neuropsychologic correlates of ful
## Abstract An Erratum has been published for this article in International Journal of Geriatric Psychiatry 16(11) 2001, 1085β1091. ## Background Psychotic (delusional) major depression (PMD) in the elderly is a common condition in inpatient settings. There is evidence that late age onset depress
The authors examined the relationship between self-criticism, dependency, and treatment outcome for 102 participants who met the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR; American Psychiatric Association, 2000) criteria for major depressive diso